Scientists uncover the process behind protein mutations that impact gut health, Crohn’s Disease and inflammatory bowel disease

By Ana Gajic A new study led by researchers at St. Michael’s Hospital and the Princess Margaret Cancer Centre in Canada and Zhejiang University School of Medicine in China has uncovered why a protein mutation that causes inflammatory bowel diseases is dysfunctional. Published today in Science, the research focused on nucleotide-binding oligomerization domain-containing protein 1 and… Read More »

FDA Approves Biorphen (phenylephrine hydrochloride) Ready-to-Use Injection for Hypotension During Anesthesia

FDA Approves Biorphen (phenylephrine hydrochloride) Ready-to-Use Injection for Hypotension During Anesthesia Print this page DEER PARK, Ill., Oct. 22, 2019 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc. (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced that the U.S. Food and Drug Administration (FDA) has approved Biorphen, the first… Read More »